{"id":512141,"date":"2021-07-13T03:04:01","date_gmt":"2021-07-13T07:04:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/"},"modified":"2021-07-13T03:04:01","modified_gmt":"2021-07-13T07:04:01","slug":"ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/","title":{"rendered":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">July 12, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0The <i>Ocugen, Inc.<\/i> class action lawsuit charges Ocugen, Inc. (NASDAQ: OCGN) and certain of its top executives with violations of the Securities Exchange Act of 1934 and seeks to represent purchasers of Ocugen securities between <span class=\"xn-chron\">February 2, 2021<\/span> and <span class=\"xn-chron\">June 10, 2021<\/span>, inclusive (the &#8220;Class Period&#8221;).\u00a0 The <i>Ocugen<\/i> class action lawsuit (<i>Nicanor v. Ocugen, Inc.<\/i>, No. 21-cv-02725) was commenced on <span class=\"xn-chron\">June 17, 2021<\/span> in the Eastern District of <span class=\"xn-location\">Pennsylvania<\/span> and is assigned to Judge <span class=\"xn-person\">C. Darnell Jones, II.<\/span><\/p>\n<p>\n        <b>If you suffered substantial losses and wish to serve as lead plaintiff of the <i>Ocugen<\/i> class action lawsuit, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3226019-1&amp;h=2743048319&amp;u=https%3A%2F%2Fwww.rgrdlaw.com%2Fcases-ocugen-inc-class-action-lawsuit.html&amp;a=please+provide+your+information+by+clicking+here\" rel=\"nofollow noopener\">please provide your information by clicking here<\/a>.\u00a0 You can also contact attorney <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3226019-1&amp;h=4064756077&amp;u=https%3A%2F%2Fwww.rgrdlaw.com%2Fattorneys-Juan-Carlos-Sanchez.html&amp;a=J.C.+Sanchez\" rel=\"nofollow noopener\">J.C. Sanchez<\/a> of Robbins Geller by calling 800\/449-4900 or via e-mail at <a target=\"_blank\" href=\"mailto:jsanchez@rgrdlaw.com\" rel=\"nofollow noopener\">jsanchez@rgrdlaw.com<\/a>.\u00a0 Lead plaintiff motions for the <i>Ocugen<\/i> class action lawsuit must be filed with the court no later than <span class=\"xn-chron\">August 17, 2021<\/span>.<\/b>\n      <\/p>\n<p>\n        <b>CASE ALLEGATIONS<\/b>:\u00a0The <i>Ocugen <\/i>class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) the information that Ocugen submitted to the U.S. Food and Drug Administration (&#8220;FDA&#8221;) was insufficient to support an Emergency Use Authorization (&#8220;EUA&#8221;); (ii) Ocugen would not file an EUA with the FDA; and (iii) as a result, Ocugen&#8217;s financial statements, as well as defendants&#8217; statements about Ocugen&#8217;s business, operations, and prospects were false and misleading and\/or lacked a reasonable basis.<\/p>\n<p>On <span class=\"xn-chron\">June 10, 2021<\/span>, Ocugen issued a press release announcing that it would pursue a biologics license application (&#8220;BLA&#8221;) with the FDA instead of the previously announced EUA.\u00a0 In doing so, Ocugen revealed that &#8220;[t]he FDA provided feedback to Ocugen regarding the Master File the Company had previously submitted and recommended that Ocugen pursue a BLA submission instead of an EUA application for its vaccine candidate and requested additional information and data.\u00a0 Ocugen is in discussions with the FDA to understand the additional information required to support a BLA submission.\u00a0 The Company anticipates that data from an additional clinical trial will be required to support the submission.&#8221;\u00a0 On this news, the price of Ocugen&#8217;s stock fell more than 28%, damaging investors.<\/p>\n<p>\n        <b>THE LEAD PLAINTIFF PROCESS<\/b>:\u00a0The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Ocugen securities during the Class Period to seek appointment as lead plaintiff in the <i>Ocugen <\/i>class action lawsuit.\u00a0 A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.\u00a0 A lead plaintiff acts on behalf of all other class members in directing the <i>Ocugen <\/i>class action lawsuit.\u00a0 The lead plaintiff can select a law firm of its choice to litigate the <i>Ocugen<\/i> class action lawsuit.\u00a0 An investor&#8217;s ability to share in any potential future recovery of the <i>Ocugen<\/i> class action lawsuit is not dependent upon serving as lead plaintiff.\u00a0 <\/p>\n<p>\n        <b>ABOUT ROBBINS GELLER RUDMAN &amp; DOWD LLP<\/b>:\u00a0With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman &amp; Dowd LLP is the largest U.S. law firm representing investors in securities class actions.\u00a0 Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever \u2013 <span class=\"xn-money\">$7.2 billion<\/span> \u2013 in <i>In re Enron Corp. Sec. Litig.<\/i>\u00a0 The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering <span class=\"xn-money\">$1.6 billion<\/span> for investors last year, more than double the amount recovered by any other securities plaintiffs&#8217; firm.\u00a0 Please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3226019-1&amp;h=505865370&amp;u=https%3A%2F%2Fwww.rgrdlaw.com%2Ffirm.html&amp;a=https%3A%2F%2Fwww.rgrdlaw.com%2Ffirm.html\" rel=\"nofollow noopener\">https:\/\/www.rgrdlaw.com\/firm.html<\/a> for more information.<\/p>\n<p>Attorney advertising.<br \/>Past results do not guarantee future outcomes.<br \/>Services may be performed by attorneys in any of our offices.<\/p>\n<p>Contact:<br \/>Robbins <span class=\"xn-person\">Geller Rudman<\/span> &amp; Dowd LLP<br \/>655 W. Broadway, <span class=\"xn-location\">San Diego<\/span>, CA\u00a0 92101 <br \/>J.C. Sanchez, 800-449-4900<br \/><a target=\"_blank\" href=\"mailto:jsanchez@rgrdlaw.com\" rel=\"nofollow noopener\">jsanchez@rgrdlaw.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit---ocgn-301332208.html\">https:\/\/www.prnewswire.com\/news-releases\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit&#8212;ocgn-301332208.html<\/a><\/p>\n<p>SOURCE  Robbins Geller Rudman &amp; Dowd LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA41199&amp;Transmission_Id=202107130300PR_NEWS_USPR_____LA41199&amp;DateId=20210713\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO, July 12, 2021 \/PRNewswire\/ &#8212;\u00a0The Ocugen, Inc. class action lawsuit charges Ocugen, Inc. (NASDAQ: OCGN) and certain of its top executives with violations of the Securities Exchange Act of 1934 and seeks to represent purchasers of Ocugen securities between February 2, 2021 and June 10, 2021, inclusive (the &#8220;Class Period&#8221;).\u00a0 The Ocugen class action lawsuit (Nicanor v. Ocugen, Inc., No. 21-cv-02725) was commenced on June 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge C. Darnell Jones, II. If you suffered substantial losses and wish to serve as lead plaintiff of the Ocugen class action lawsuit, please provide your information by clicking here.\u00a0 You can also contact attorney J.C. Sanchez of Robbins &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-512141","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, July 12, 2021 \/PRNewswire\/ &#8212;\u00a0The Ocugen, Inc. class action lawsuit charges Ocugen, Inc. (NASDAQ: OCGN) and certain of its top executives with violations of the Securities Exchange Act of 1934 and seeks to represent purchasers of Ocugen securities between February 2, 2021 and June 10, 2021, inclusive (the &#8220;Class Period&#8221;).\u00a0 The Ocugen class action lawsuit (Nicanor v. Ocugen, Inc., No. 21-cv-02725) was commenced on June 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge C. Darnell Jones, II. If you suffered substantial losses and wish to serve as lead plaintiff of the Ocugen class action lawsuit, please provide your information by clicking here.\u00a0 You can also contact attorney J.C. Sanchez of Robbins &hellip; Continue reading &quot;OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-13T07:04:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN\",\"datePublished\":\"2021-07-13T07:04:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/\"},\"wordCount\":651,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA41199&amp;sd=2021-07-13\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/\",\"name\":\"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA41199&amp;sd=2021-07-13\",\"datePublished\":\"2021-07-13T07:04:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA41199&amp;sd=2021-07-13\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA41199&amp;sd=2021-07-13\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/","og_locale":"en_US","og_type":"article","og_title":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, July 12, 2021 \/PRNewswire\/ &#8212;\u00a0The Ocugen, Inc. class action lawsuit charges Ocugen, Inc. (NASDAQ: OCGN) and certain of its top executives with violations of the Securities Exchange Act of 1934 and seeks to represent purchasers of Ocugen securities between February 2, 2021 and June 10, 2021, inclusive (the &#8220;Class Period&#8221;).\u00a0 The Ocugen class action lawsuit (Nicanor v. Ocugen, Inc., No. 21-cv-02725) was commenced on June 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge C. Darnell Jones, II. If you suffered substantial losses and wish to serve as lead plaintiff of the Ocugen class action lawsuit, please provide your information by clicking here.\u00a0 You can also contact attorney J.C. Sanchez of Robbins &hellip; Continue reading \"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-13T07:04:01+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN","datePublished":"2021-07-13T07:04:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/"},"wordCount":651,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/","name":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13","datePublished":"2021-07-13T07:04:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA41199&amp;sd=2021-07-13"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-investor-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-ocugen-inc-class-action-lawsuit-ocgn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OCUGEN INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit &#8211; OCGN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/512141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=512141"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/512141\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=512141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=512141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=512141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}